BioLegend Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 665

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $5.7B

BioLegend General Information

Description

Operator of a biotechnology company specializing in biomedical antibodies. The company develops antibodies and reagents like flow cytometry, cell biology, and functional reagents for research in immunology, cancer, and stem cells and development, enabling scientists to accelerate research and discovery with a diverse set of areas.

Contact Information

Website
www.biolegend.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 8999 BioLegend Way
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Discovery Tools (Healthcare)
Parent Company
Revvity
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 8999 BioLegend Way
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioLegend Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 17-Sep-2021 $5.7B Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view BioLegend’s complete valuation and funding history, request access »

BioLegend Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company specializing in biomedical antibodies. The company develops antibodies and reagents
Discovery Tools (Healthcare)
San Diego, CA
665 As of 2024

Poway, CA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioLegend Competitors (34)

One of BioLegend’s 34 competitors is ProSci (Biotechnology), a Private Equity-Backed company based in Poway, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProSci (Biotechnology) Private Equity-Backed Poway, CA
Abcam Corporate Backed or Acquired Cambridge, United Kingdom
GeneTex Formerly VC-backed Irvine, CA
Miltenyi Biotec Private Debt Financed Bergisch Gladbach, Germany
Novus Biologicals Formerly PE-Backed Centennial, CO
You’re viewing 5 of 34 competitors. Get the full list »

BioLegend Patents

  • 129

    Total Documents Applications and Grants

  • Total Patents Families

  • 34

    Granted

  • 55

    Pending

  • Expiring in next 12 mo

BioLegend Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260133112-A1 Control cell populations for detection of paroxysmal nocturnal hemoglobinuria Pending 12-Nov-2024
WO-2026106937-A1 Control cell populations for detection of paroxysmal nocturnal hemoglobinuria Pending 12-Nov-2024
US-20260079168-A1 Tau phospho (thr217) binding antibodies and antigen binding fragments thereof Pending 19-Sep-2024
WO-2026064249-A1 Tau phospho (thr217) binding antibodies and antigen binding fragments thereof Pending 19-Sep-2024
US-20250382358-A1 Methods and compositions relating to mouse monoclonal anti-g4s linker antibodies Pending 18-Jun-2024 C07K16/18
To view BioLegend’s complete patent history, request access »

BioLegend Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioLegend Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
NTU Innovation and Incubation Center Accelerator/Incubator
To view BioLegend’s complete investors history, request access »

BioLegend Investments & Acquisitions (4)

BioLegend’s most recent deal was a Seed Round with Kura Care for . The deal was made on 01-Dec-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kura Care 01-Dec-2022 Seed Round Outcome Management (Healthcare)
Qognit 22-Dec-2021 Merger/Acquisition Other Healthcare Technology Systems
NeoClone (Antibody Reagents Business) 01-Oct-2014 Merger/Acquisition Discovery Tools (Healthcare)
Covance Antibody Services 02-Sep-2014 Merger/Acquisition Biotechnology
To view BioLegend’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

BioLegend Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Qognit San Carlos, CA 2016

BioLegend FAQs

  • When was BioLegend founded?

    BioLegend was founded in 2002.

  • Where is BioLegend headquartered?

    BioLegend is headquartered in San Diego, CA.

  • What is the size of BioLegend?

    BioLegend has 665 total employees.

  • What industry is BioLegend in?

    BioLegend’s primary industry is Discovery Tools (Healthcare).

  • Is BioLegend a private or public company?

    BioLegend is a Private company.

  • What is the current valuation of BioLegend?

    The current valuation of BioLegend is .

  • What is BioLegend’s current revenue?

    The current revenue for BioLegend is .

  • Who are BioLegend’s investors?

    NTU Innovation and Incubation Center has invested in BioLegend.

  • Who are BioLegend’s competitors?

    ProSci (Biotechnology), Abcam, GeneTex, Miltenyi Biotec, and Novus Biologicals are some of the 34 competitors of BioLegend.

  • When was BioLegend acquired?

    BioLegend was acquired on 17-Sep-2021.

  • Who acquired BioLegend?

    BioLegend was acquired by Revvity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process